Thermo Fisher Scientific
Change company
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
IE
US
US
US
US
US
IN
US
US
US
US
US
US
US
US
US
US
US
US
AU
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
JP
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
BM
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
CA
US
US
US
US
US
US
US
US
US
US
US
US
US
US
US
Track Thermo Fisher Scientific in real time with a live news feed covering Thermo Fisher Scientific stock news, official press releases, company announcements, and an archive of historical Thermo Fisher Scientific news. ...more
Loading news...
Loading more...
7:37 AM | Thursday | Sep 10, 2026
Sign in to download news snippet
On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL).
Read full articleNo data available for this time period.
Change the time range to see results.
On CNBC's “Halftime Report Final Trades,” Bryn Talkington, managing partner of Requisite Capital Management, picked Horizon Kinetics Inflation Beneficiaries ETF (NYSE:INFL).
Read full article
Prefer to listen? Hear this as a ~5-minute audio briefing on The GuruFocus Brief.Stock NewsAnthropic researcher resigns over AI safety concerns: Jacob Coxon, a
Read full articleBaird Financial Group Inc. lowered its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 18.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 167,777 shares of the medical research company's stock after selling 39,226 shares during the quarter.
Baird
Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.
Read full article
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Read full article
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Read full article
California State Teachers Retirement System grew its position in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 49,331.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 282,654,735 shares of the medical research company's stock after acquiring an additional 282,082,924
Read full article
Thermo Fisher's growth is gaining momentum as acquisitions strengthen its life sciences reach, but macro risks and competition remain concerns.
Read full article
Clark Howard named a specific age when corporate America tends to push workers out, and it falls years before most people's retirement plans even begin to account for income gaps, portfolio shortfalls, or Social Security decisions.
Read full articleMarkets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names ranging from Broadcom to Moderna that could reshape your portfolio positioning.
Read full article
Healthcare is moving away from the traditional model of mass-produced, one-size-fits-all treatments toward individualized therapies. This evolution in medicine aims to provide treatments that are not only more effective but also carry a lower risk of adverse side effects by aligning with a patient's unique biology.
Read full article
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance. Laboratories performing absorbance-based analysis are under increasing pressure to generate reliable data.
Read full article
Thermo Fisher's EMPAD G2 detector enhances 4D STEM imaging speed, sensitivity and workflow integration, strengthening its Analytical Instruments portfolio.
Read full article
Beacon Pointe Advisors LLC purchased a new position in Thermo Fisher Scientific Inc. (NYSE: TMO) during the undefined quarter, according to its most recent disclosure with the SEC. The fund purchased 37,709 shares of the medical research company's stock, valued at approximately $18,906,000. Several other hedge funds also recently modified their holdings of
Read full article
Ausdal Financial Partners Inc. bought a new stake in Thermo Fisher Scientific Inc. (NYSE: TMO) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 910 shares of the medical research company's stock, valued at approximately $456,000. Several other hedge funds and other
Read full article
No data available for this time period.
Change the time range to see results.